- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Oct 18, 2019 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Oct 18, 2019 | T-1420-18 | CMC | Ncs Multistage Inc. V. Kobold Corporation, Et Al (Patent) | Calgary | 1 h |
| Oct 18, 2019 | T-1779-18 | CMC | Privacy Commissioner Of Canada (unknown) | Montréal | 1 h |
| Oct 21, 2019 | T-608-17 | T | Seedlings Life Science Ventures,llc V. Pfizer Canada Ulc / Pfizer Canada Sri (Patent) | Ottawa | 15 d |
| Oct 21, 2019 | T-827-19 | M | Janssen Inc V. Attorney General Of Canada Et Al (unknown) | Toronto | 2 h |
| Oct 21, 2019 | T-1924-17 | CMC | Bell Canada Et Al V. Watchnsavenow Inc. Et Al (Copyright) | Ottawa | 1 h |
| Oct 21, 2019 | T-1683-18 | CMC | Tbv Productions, Llc V. Doe #1 Et Al (Copyright) | Toronto | 30 m |
| Oct 21, 2019 | T-954-18 | CMC | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 30 m |
| Oct 21, 2019 | T-2141-18 | CMC | Am Royalties Limited Partnership Et Al V. First Bitcoin Capital Corp Et Al (Trade Mark) | Toronto | 30 m |
| Oct 21, 2019 | T-701-18 | CMC | Walter Fleming V. Sharron Thompson Et Al. (Patent) | Toronto | 1 h |
| Oct 21, 2019 | T-806-19 | CMC | Bayer Inc Et Al. V. Sandoz Canada Inc. (Patent - Rivaroxaban*) | Ottawa | 1 h |
| Oct 21, 2019 | T-1387-19 | CMC | Cubist Pharmaceuticals Llc, Et Al V. Dr. Reddy's Laboratories Limited Et Al (Patent - Daptomycin*) | Ottawa | 1 h |
| Oct 21, 2019 | T-704-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Oct 21, 2019 | T-705-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Oct 21, 2019 | T-708-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Oct 21, 2019 | T-768-19 | CMC | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Oct 21, 2019 | T-770-19 | CMC | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Oct 22, 2019 | T-921-17 | M | Rovi Guides, Inc. Et Al V. Videotron G.p. Et Al (Patent) | Toronto | 3 h |
| Oct 22, 2019 | T-1252-19 | M | Modpro Containers Ltd Et Al. V. Tangle Pools Et Al. (unknown) | Vancouver | 1.5 h |
| Oct 22, 2019 | T-411-19 | M | Exterior Wall Systems, Ltd. Et Al V. Ritz Architectural Systems Inc., Et Al (Trade Mark) | Toronto | 2 h |
| Oct 22, 2019 | T-1069-14 | M | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Toronto | 3 h |
| Oct 23, 2019 | T-130-18 | T | Alexander Stross V. Trend Hunter Inc., Jeremy Gutsche (Copyright) | Toronto | 1.3 d |
| Oct 23, 2019 | T-350-18 | TMC | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Ottawa | 1 h |
| Oct 23, 2019 | T-351-18 | TMC | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Ottawa | 1 h |
| Oct 23, 2019 | T-396-13 | CMC | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 30 m |
| Oct 23, 2019 | T-1642-16 | M | Fluid Energy Group Ltd. V. Mud Master Drilling Fluid Services Ltd. (Patent) | Ottawa | 2 h |
| Oct 24, 2019 | T-449-17 | M | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 1 d |
| Oct 24, 2019 | T-1248-19 | CMC | Apotex Inc. V. Minister Of Health And Agc (unknown) | Toronto | 30 m |
| Oct 24, 2019 | T-795-19 | CMC | Blown Away Glass Studio Inc. V. Marble Media Inc. Et Al (Trade Mark) | Toronto | 30 m |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Oct 21, 2019 | T-608-17 | Seedlings Life Science Ventures,llc V. Pfizer Canada Ulc / Pfizer Canada Sri (Patent) | Ottawa | 15 d |
| Oct 23, 2019 | T-130-18 | Alexander Stross V. Trend Hunter Inc., Jeremy Gutsche (Copyright) | Toronto | 1.3 d |
| Nov 4, 2019 | T-351-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 9 d |
| Nov 4, 2019 | T-350-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 9 d |
| Nov 6, 2019 | T-2025-11 | Bombardier Recreational Products Inc. V. Arctic Cat, Inc. (Patent) | Montréal | 2 d |
| Nov 18, 2019 | T-304-16 | Wi-lan Inc. V. Rogers Communications Canada Inc. (Patent) | Toronto | 15 d |
| Nov 18, 2019 | T-303-16 | Wi-lan Inc. V. Bell Mobility Inc. (Patent) | Toronto | 15 d |
| Nov 18, 2019 | T-301-16 | Wi-lan Inc. V. Telus Corporation Et Al. (Patent) | Toronto | 15 d |
| Nov 25, 2019 | T-1151-17 | Molson Canada 2005 V. Labatt Brewing Company Limited/la Brasserie Labatt (Trade Mark) | Toronto | 10 d |
| Nov 25, 2019 | T-377-16 | Biofert Manufacturing Inc. V. Agrisol Manufacturing Inc. And Others (Trade Mark) | Vancouver | 14 d |
| Nov 25, 2019 | T-351-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 2 d |
| Nov 25, 2019 | T-350-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 2 d |
| Dec 2, 2019 | T-1632-16 | Eli Lilly Canada Inc., Eli Lilly And Company Et Al. V. Apotex Inc. (Patent - Tadalafil*) | Ottawa | 15 d |
| Dec 2, 2019 | T-1631-16 | Eli Lilly Canada Inc. Et Al. V. Teva Canada Limited (Patent - Tadalafil*) | Ottawa | 15 d |
| Dec 2, 2019 | T-1627-16 | Eli Lilly Canada Inc. Et Al. V. Mylan Pharmaceuticals Ulc (Patent - Tadalafil*) | Ottawa | 15 d |
| Dec 2, 2019 | T-1623-16 | Eli Lilly Canada Inc. Et Al V. Pharmascience Inc. (Patent - Tadalafil*) | Ottawa | 15 d |
| Dec 3, 2019 | T-896-15 | Georgetown Rail Equipment Company V. Rail Radar Inc. Et Al (Patent) | Toronto | 1 d |
| Jan 13, 2020 | T-1632-16 | Eli Lilly Canada Inc., Eli Lilly And Company Et Al. V. Apotex Inc. (Patent - Tadalafil*) | Ottawa | 5 d |
| Jan 20, 2020 | T-1627-16 | Eli Lilly Canada Inc. Et Al. V. Mylan Pharmaceuticals Ulc (Patent - Tadalafil*) | Ottawa | 5 d |
| Jan 20, 2020 | T-741-18 | Amgen Inc. Et Al V. Pfizer Canada Ulc (Patent - Filgrastim*) | Toronto | 10 d |
| Jan 27, 2020 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 15 d |
| Jan 27, 2020 | T-1623-16 | Eli Lilly Canada Inc. Et Al V. Pharmascience Inc. (Patent - Tadalafil*) | Ottawa | 5 d |
| Feb 3, 2020 | T-546-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Et Al (Patent) | Montréal | 23 d |
| Feb 3, 2020 | T-353-18 | Janssen Inc. Et Al V. Teva Canada Limited (Patent - Paliperidone*) | Toronto | 15 d |
| Feb 3, 2020 | T-1631-16 | Eli Lilly Canada Inc. Et Al. V. Teva Canada Limited (Patent - Tadalafil*) | Ottawa | 5 d |
| Feb 10, 2020 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Winnipeg | 10 d |
| Mar 2, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Toronto | 10 d |
| Mar 2, 2020 | T-1163-18 | Biogen Canada Inc Et Al V. Taro Pharmaceuticals Inc (Patent - Fampridine*) | Toronto | 10 d |
| Mar 9, 2020 | T-921-17 | Rovi Guides, Inc. Et Al V. Videotron G.p. Et Al (Patent) | Toronto | 20 d |
| Mar 23, 2020 | T-168-18 | Lickerish, Ltd. V. Airg Inc. (Copyright) | Calgary | 3 d |
| Mar 30, 2020 | T-1529-18 | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Mar 30, 2020 | T-1527-18 | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Apr 20, 2020 | T-1069-14 | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Toronto | 10 d |
| Apr 20, 2020 | T-1503-18 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Filgrastim*) | Toronto | 10 d |
| Apr 20, 2020 | T-902-19 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 10 d |
| May 4, 2020 | T-1711-16 | Houghton International Inc Et Al V. Nts-northern Technical Solutions Inc (Patent) | Toronto | 7 d |
| May 4, 2020 | T-1977-18 | Celgene Inc. Et Al V. Apotex Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| May 4, 2020 | T-1976-18 | Celgene Inc. Et Al V. Apotex Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| May 4, 2020 | T-1975-18 | Celgene Inc. Et Al V. Apotex Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| May 4, 2020 | T-1974-18 | Celgene Inc. Et Al V. Apotex Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| May 4, 2020 | T-569-17 | J.r. Simplot Company V. Mccain Foods Ltd. V. Simplot Canada (ii) Limited (Trade Mark) | Ottawa | 7 d |
| May 6, 2020 | T-1503-18 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Filgrastim*) | Toronto | 2 d |
| May 11, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 13 d |
| May 25, 2020 | T-206-18 | Rovi Guides, Inc. Et Al V. Telus Corporation Et Al (Patent) | Toronto | 20 d |
| May 25, 2020 | T-113-18 | Rovi Guides Inc Et Al V. Bce Inc. Et Al (Patent) | Toronto | 20 d |
| Jun 1, 2020 | T-448-17 | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Calgary | 14 d |
| Jun 15, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 10 d |
| Jul 15, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Ottawa | 3 d |
| Aug 24, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 24, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 31, 2020 | T-913-17 | Canadian National Railway Company V. Bnsf Railway Company Et Al. (Patent) | Toronto | 14 d |
| Sep 14, 2020 | T-504-19 | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-503-19 | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-98-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-97-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Ottawa | 10 d |
| Oct 13, 2020 | T-954-18 | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 13 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Nov 5, 2019 | T-1603-18 | Glaxosmithkline Biologicals S.a. V. The Minister Of Health | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Nov 7, 2019 | T-1812-18 | Wayne S. Cusitar V. The Attorney General Of Canada | Patent - Appeal of a Decision of Commissioner | Fredericton | 1 d |
| Nov 14, 2019 | T-1229-19 | Shueisha Inc. V. Shaw Communications Inc. Et Al. | Copyright Infringement [Applications] | Toronto | 1.5 h |
| Dec 3, 2019 | T-23-19 | Arterra Wines Canada Inc. V. Diageo North America Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Dec 4, 2019 | T-2008-16 | Wissam Aoun V. Agc | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Dec 5, 2019 | T-784-19 | David Suzuki Foundation Et Al V. Minister Of Health Et Al & Croplife Canada | S. 18.1 Application for Judicial Review | Toronto | 2 d |
| Jan 13, 2020 | T-1736-18 | Obsidian Group Inc. V. The Attorney General Of Canada | S. 18.1 Application for Judicial Review | Toronto | 4 h |
| Jan 15, 2020 | T-353-19 | Viiv Healthcare Ulc V. The Minister Of Health - Dolutegravir* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Oct 28, 2019 | A-338-18 | Hospira Healthcare Corporation V. The Kennedy Trust For Rheumatology Researc - Infliximab* | Appeal (S.27 - Final) - Patent Act [from T-396-13 - Patent Impeachment] | Toronto | 2 d |
| Oct 28, 2019 | A-326-16 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology Et A - Infliximab* | Appeal (S.27 - Interloc.) - Others [from T-396-13 - Patent Impeachment] | Toronto | 1.7 d |
| Oct 28, 2019 | A-328-16 | Hospira Healthcare Corporation V The Kennedy Institute Of Rheumatology - Infliximab* | Appeal (S.27 - Interloc.) - Others [from T-396-13 - Patent Impeachment] | Toronto | 1.7 d |
| Oct 28, 2019 | A-329-18 | Hospira Healthcare Corp Et Al. V. The Kennedy Trust For Rheumatology Et Al. - Infliximab* | Appeal (S.27 - Interloc.) - Patent Act [from T-396-13 - Patent Impeachment] | Toronto | 1.7 d |
| Oct 28, 2019 | A-354-18 | Hospira Healthcare Corp. V. Kennedy Trust For Rheumatology Research - Infliximab* | Statutory Appeal - Others [from T-396-13 - Patent Impeachment] | Toronto | 1.7 d |
| Oct 28, 2019 | A-360-18 | Hospira Healthcare Corporation V The Kennedy Institute Of Rheumatology - Infliximab* | Appeal (S.27 - Interloc.) - Patent Act | Toronto | 1.7 d |
| Oct 30, 2019 | A-413-18 | Igor Stukanov V. Agc | Appeal (S.27 - Final) - Patent Act [from T-347-18 - Patent - Appeal of a Decision of Commissioner] | Toronto | 2 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.